| 0 (0%) | 12-05 10:09 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 16.57 | 1-year : | 19.36 |
| Resists | First : | 14.19 | Second : | 16.57 |
| Pivot price | 13.96 |
|||
| Supports | First : | 13.58 |
Second : | 13.19 |
| MAs | MA(5) : | 14.07 |
MA(20) : | 13.88 |
| MA(100) : | 14.17 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 88 |
D(3) : | 85.3 |
| RSI | RSI(14): 56 |
|||
| 52-week | High : | 16.17 | Low : | 12.26 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ RDY ] has closed below upper band by 14.1%. Bollinger Bands are 57% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 14.18 - 14.24 | 14.24 - 14.28 |
| Low: | 13.95 - 14.01 | 14.01 - 14.07 |
| Close: | 14.03 - 14.13 | 14.13 - 14.22 |
Wed, 03 Dec 2025
Fisher Asset Management LLC Sells 522,987 Shares of Dr. Reddy's Laboratories Ltd $RDY - MarketBeat
Wed, 03 Dec 2025
American Century Companies Inc. Acquires 133,045 Shares of Dr. Reddy's Laboratories Ltd $RDY - MarketBeat
Tue, 02 Dec 2025
Virtus Advisers LLC Purchases Shares of 118,945 Dr. Reddy's Laboratories Ltd $RDY - MarketBeat
Tue, 02 Dec 2025
Aurigene Oncology (RDY) posts early Phase 1 AUR112 data with 63.6% ORR - Stock Titan
Mon, 01 Dec 2025
Final Call for iBUYPOWER Cyber Monday Deals + More - XboxEra
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 833 (M) |
| Shares Float | 592 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 13.7 (%) |
| Shares Short | 8,050 (K) |
| Shares Short P.Month | 8,550 (K) |
| EPS | 0.79 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 430.6 |
| Profit Margin | 17.1 % |
| Operating Margin | 18.4 % |
| Return on Assets (ttm) | 8.7 % |
| Return on Equity (ttm) | 17.3 % |
| Qtrly Rev. Growth | 9.8 % |
| Gross Profit (p.s.) | 231.92 |
| Sales Per Share | 410.98 |
| EBITDA (p.s.) | 106.5 |
| Qtrly Earnings Growth | 14.6 % |
| Operating Cash Flow | 58,820 (M) |
| Levered Free Cash Flow | 13,560 (M) |
| PE Ratio | 17.89 |
| PEG Ratio | 0 |
| Price to Book value | 0.03 |
| Price to Sales | 0.03 |
| Price to Cash Flow | 0.2 |
| Dividend | 0.09 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |